Naltrexone and Mounjaro require a review of the exact prescriptions and their purposes before they are used together. Oral naltrexone, the naltrexone–bupropion product Contrave, and tirzepatide are different treatments. A shared interest in weight management does not establish that combining them will improve results or be appropriate for you.
There is also an important evidence update: a frequently cited 2024 study of adding bupropion/naltrexone to a GLP-1 treatment was retracted in December 2025. Its reported added weight-loss benefit should not be presented as an established finding. This guide separates those questions so you can have a more useful conversation with the prescribing team.
Which naltrexone product are you asking about?
Start with the name on the pharmacy label. The reviewed oral naltrexone tablet label describes treatment of alcohol dependence and blocking the effects of externally administered opioids within an appropriate addiction-management plan. It is not a label for a stand-alone weight-loss medicine. Oral naltrexone label.
Contrave is a particular extended-release combination of naltrexone and bupropion. Its current label has an adult weight-management indication alongside reduced-calorie eating and increased physical activity. The label discourages adding another naltrexone-containing product and contraindicates another bupropion-containing product. Contrave prescribing information.
Those distinctions matter if your list already includes Wellbutrin, generic bupropion, or a separate naltrexone prescription. Taking a component for one condition does not make it interchangeable with the combination product. Our bupropion and weight-loss guide explains the different products and the limits of translating appetite changes into a treatment recommendation.
Ask the pharmacy to help identify an unfamiliar tablet rather than relying on its color, an online photo, or a nickname. Include the release formulation and the written directions in your list. If you use an injectable naltrexone product, tell the clinician that explicitly; this article’s oral-tablet discussion cannot substitute for its separate instructions.
Mounjaro and Zepbound also have different label contexts
Mounjaro contains tirzepatide. Its current U.S. label includes improving glucose control in adults and children aged 10 and older with type 2 diabetes, plus a separate adult cardiovascular indication in the specified diabetes population. That does not turn every tirzepatide prescription into the same service or indication. Mounjaro label.
Zepbound is another branded tirzepatide product with adult weight-management and obstructive-sleep-apnea indications in defined populations. Zepbound label. A clinician should identify which condition is being treated, which exact product is prescribed, and how response will be assessed.
For broader comparisons, see our GLP-1 product and dosage overview and Mounjaro without diabetes guide. Neither a brand comparison nor an online discussion authorizes substituting one product, concentration, pen, or vial for another.
| Question | Detail to bring | Why it matters |
|---|---|---|
| Which naltrexone treatment? | Separate oral tablet, combination product, or another formulation | Ingredients, indications and directions differ. |
| Which tirzepatide treatment? | Brand, presentation and actual prescription | A general ingredient name does not identify the full product. |
| What is each treatment for? | The condition and intended benefit | Weight change may be only one part of the care plan. |
| Who coordinates the prescriptions? | Prescriber names and pharmacy | Each team needs the complete current list. |
| What changed recently? | New treatment, dose change, symptoms or missed medicines | Timing helps guide a review without proving the cause. |
What does the retracted combination study mean?
The original study was a retrospective cohort, meaning researchers examined existing treatment records rather than assigning participants to a new randomized combination trial. It studied bupropion/naltrexone added to a GLP-1 analogue; it was not a direct trial establishing the effect of oral naltrexone alone with Mounjaro.
The journal’s retraction note says an independent assessment could not fully reproduce the statistical analysis and could not confirm the principal finding about added weight loss. The authors disagreed with the retraction. Journal retraction note.
A retraction does not answer every future research question about combinations. It does mean this study is an unsuitable basis for promising an extra percentage of weight loss, recommending an add-on, or describing the pairing as proven. Old article summaries and social posts may still repeat the original numbers without the update.
When you encounter a combination claim, ask which exact ingredients were studied, whether the study is still valid, what comparison group was used, and whether the participants resemble the person considering treatment. “A study mentioned both medicines” is much less informative than those details.
An interaction check is one part of the decision
A pharmacist can review interactions, duplicate ingredients and administration directions. A prescriber also needs to weigh each treatment’s purpose, your medical history, symptoms and follow-up. Finding no simple scheduling conflict does not establish that adding a medicine is worthwhile.
Tirzepatide can delay stomach emptying and affect absorption of oral medicines. The Mounjaro label calls for caution with oral treatment, particularly medicines whose effective concentrations need close monitoring. Oral-medication section. It does not provide a universal number of hours that clears oral naltrexone for everyone.
If you vomit after swallowing a tablet, ask for instructions about that actual product and episode. Do not assume the whole tablet was lost or automatically take another. Similarly, repeated nausea or trouble keeping medicines down deserves an assessment rather than increasingly complicated homemade schedules.
Tell the team about contraceptive tablets and other medicines too. A review focused only on the two names in the headline can miss an important issue elsewhere in the list. Include supplements, occasional pain treatment, cough remedies and prescriptions from another clinic.
Why opioid and pain-treatment history is essential
Naltrexone blocks opioid effects. Its label contraindicates use in people receiving opioid pain medicines or with current opioid dependence and describes the risk of precipitating severe withdrawal. It also warns about overdose risk when someone attempts to overcome the blockade or returns to opioids after treatment. Naltrexone safety information.
This is a reason for coordinated medical care, not a reason to stop pain treatment or addiction treatment on your own. Tell the clinician about recent opioid exposure, including tramadol, methadone or buprenorphine, and any upcoming procedure that may involve pain treatment. The team should plan the transition or procedure with the relevant specialists.
Keep the medicine list accessible for emergency care. If an unexpected injury occurs, tell the treating team that you use naltrexone. Do not increase an opioid amount because an ordinary dose seems ineffective, and do not use an internet “opioid-free interval” as a personal clearance test.
Liver, mood, blood pressure and digestive symptoms
The oral naltrexone information includes liver-injury warnings. MedlinePlus lists symptoms such as yellow skin or eyes, dark urine and persistent upper-right abdominal pain as reasons for immediate medical contact under its instructions. Naltrexone patient information. Report existing liver disease and relevant symptoms before starting or changing treatment.
Contrave adds bupropion-specific considerations. Its manufacturer safety information includes seizure risk, mood monitoring and possible increases in blood pressure or heart rate. Those cannot be assumed to apply identically to naltrexone alone. Contrave safety information.
Digestive symptoms need their own review. Tirzepatide’s label describes dehydration-related kidney injury following gastrointestinal effects. Mounjaro warning. Poor intake, persistent vomiting or inability to keep fluids down should be assessed promptly. Do not interpret feeling unwell as evidence that a combination is “working harder.”
Our Mounjaro side-effects guide provides more context. When several treatments can affect how you feel, describe what happened and when; the clinician can investigate the cause instead of attributing every change to whichever medicine was added last.
Prepare for a coordinated appointment
Write down the exact product names, prescribed directions and start dates. Add why each was prescribed and which clinician manages it. A photo of the pharmacy labels can help if spelling or release formulations are confusing, but protect your personal details when sharing anything outside the care team.
Then describe the decision you actually need help with: continuing two existing prescriptions, considering a new add-on, reviewing unwanted effects, or finding a treatment for a different condition. These are different consultations. Ask who will handle follow-up and which symptoms require earlier contact.
Also discuss meals, hydration and everyday function. Our balanced-meal guide can help organize food questions when appetite changes. A nutrition problem should not be answered solely by adding another appetite-related medicine.
Frequently asked questions
Can I take naltrexone and Mounjaro on the same day?
That requires product-specific advice from the prescribing team or pharmacist. This article does not establish a safe same-day schedule or a required spacing interval. Explain whether the naltrexone is a separate tablet or part of Contrave and give the complete medicine list. Do not start, stop or rearrange either prescription based only on a timing answer found online.
Does adding naltrexone guarantee more weight loss?
No guarantee follows from the sources reviewed here. The retracted cohort cannot establish an added benefit, and its combination was not naltrexone alone plus Mounjaro. Ask about valid evidence for the proposed regimen, the treatment goal, alternatives and monitoring. A plateau by itself does not identify which change, if any, is appropriate.
Is Contrave the same as taking my existing tablets together?
No. Contrave is a defined extended-release prescription product. The current label has restrictions on other naltrexone and bupropion products. Do not recreate it, add ingredients, or substitute separate tablets without an explicit prescription review. Our Ozempic and Wellbutrin article addresses a related but separate medication question.
Where can I explore adult weight-management care?
The CoreAge Rx tirzepatide page explains the service. An individual consultation must determine eligibility and the exact prescription. The page does not mean the service supplies Mounjaro, Contrave, or a particular combination. Bring questions about all existing treatments so the assessment reflects the care you already receive.
Educational information for adults; individual treatment decisions require a qualified clinician. Sources reviewed October 3, 2026. Original AI-generated article images depict fictional people and objects, not patient outcomes. Other editorial images are illustrative. Graphics summarize the cited sources.
